SCMH1 Inhibitors
SCMH1 Inhibitors are a suite of chemical compounds that indirectly attenuate the functional activity of SCMH1 through diverse biochemical mechanisms. For instance, histone deacetylase inhibitors such as Trichostatin A, Mocetinostat, and Suberoylanilide Hydroxamic Acid can undermine SCMH1's role within the Polycomb repressive complexby altering the acetylation status of histones, leading to a more euchromatic and transcriptionally active chromatin state. This shift in chromatin dynamics can impede SCMH1's ability to contribute to gene silencing. Similarly, DNA methyltransferase inhibitors like 5-Azacytidine and 5-Aza-2′-Deoxycytidine can hinder SCMH1's function by inducing DNA hypomethylation, which challenges the epigenetic silencing capabilities that SCMH1 normally supports. Moreover, 3-Deazaneplanocin and DZNep, both targeting the S-adenosylhomocysteine hydrolase, may disrupt the histone methylation processes that SCMH1 is associated with, leading to a diminished capacity for gene repression.
On the other hand, Disulfiram's influence on aldehyde dehydrogenase may indirectly interfere with SCMH1 by altering the acetylation balance within the cell. Parthenolide's ability to inhibit NF-kB signaling could also have repercussions for SCMH1's role in gene regulation, as it may alter the transcriptional landscape in which SCMH1 operates. With the proteasome inhibitors Bortezomib and MG-132, the prevention of protein degradation can result in a cellular environment that is less conducive to the maintenance of the repressive states SCMH1 helps regulate, due to the accumulation of proteins that might otherwise be degraded. These inhibitors collectively work through their unique impacts on cellular pathways to attenuate the gene regulatory functions of SCMH1, without directly influencing its expression or requiring its activation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
A histone deacetylase inhibitor that can indirectly diminish SCMH1 function by altering chromatin structure and DNA accessibility. SCMH1, being associated with the Polycomb group protein complex, regulates gene expression through modifying chromatin structure. Trichostatin A's action on histones could therefore disrupt SCMH1's ability to maintain gene silencing. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A DNA methyltransferase inhibitor that can lead to hypomethylation of DNA. While SCMH1 is involved in gene silencing and methylation processes, inhibition of DNA methylation could disrupt the functional involvement of SCMH1 in these processes, potentially reducing its activity. | ||||||
Mocetinostat | 726169-73-9 | sc-364539 sc-364539B sc-364539A | 5 mg 10 mg 50 mg | $214.00 $247.00 $1463.00 | 2 | |
A selective inhibitor of histone deacetylases, which could indirectly diminish SCMH1 activity by promoting a more open chromatin state and thus interfering with the gene repression capabilities of the Polycomb repressive complex that SCMH1 is part of. | ||||||
Disulfiram | 97-77-8 | sc-205654 sc-205654A | 50 g 100 g | $53.00 $89.00 | 7 | |
An aldehyde dehydrogenase inhibitor that might affect SCMH1 indirectly by altering the acetylation status of histones or other substrates, possibly interfering with SCMH1's role in the Polycomb group protein complex and its associated gene silencing function. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $90.00 $212.00 | 24 | |
A benzamide histone deacetylase inhibitor that can indirectly diminish SCMH1 function, as histone deacetylation is critical for its repressive functions as part of the Polycomb group complex. MS-275's action on histones could therefore reduce SCMH1's gene silencing capacity. | ||||||
Parthenolide | 20554-84-1 | sc-3523 sc-3523A | 50 mg 250 mg | $81.00 $306.00 | 32 | |
A sesquiterpene lactone that can inhibit NF-kB signaling, a pathway that may be indirectly associated with SCMH1's function in gene regulation. By inhibiting this signaling, SCMH1-mediated gene silencing may be affected due to changes in transcriptional needs of cells. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
A proteasome inhibitor that can lead to the buildup of proteins within the cell. This buildup may indirectly affect the function of SCMH1 by disrupting the protein turnover required for the maintenance of the epigenetic states that SCMH1 helps regulate. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
A hypomethylating agent. It could indirectly diminish SCMH1 function by causing DNA hypomethylation and consequently disrupting the gene repression mechanisms that SCMH1 is involved with. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
A histone deacetylase inhibitor that can alter gene expression patterns and indirectly diminish SCMH1 function by affecting the chromatin remodeling processes that SCMH1 is involved in. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
A peptide aldehyde that inhibits the proteasome and ubiquitin ligases. By inhibiting protein degradation, MG-132 could indirectly affect SCMH1's role in gene regulation by disrupting the balance of histone-modifying enzymes and substrates that interact with the Polycomb group proteins. | ||||||